Document:

pri-ex1030_599.htm

 

EXHIBIT 10.30

AMENDMENT TO amended and RESTATED EMPLOYMENT AGREEMENT

AMENDMENT by and between Primerica, Inc. (the “Company”), and Peter W. Schneider (the “Executive”) dated as of the 17th day of November, 2015.

WHEREAS, the Board of Directors of the Company (the “Board”) has previously determined that it is in the best interests of the Company and its stockholders to employ the Executive as the Company’s President;

WHEREAS, the Company and the Executive entered into an Amended and Restated Employment Agreement embodying the terms of such employment dated as of January 2, 2015 (the “2015 Agreement”); and

WHEREAS, the Company and the Executive desire to modify certain terms of the 2015 Agreement;

NOW, THEREFORE, in consideration of the premises and mutual covenants contained herein and for other good and valuable consideration, the receipt of which is mutually acknowledged, the Company and the Executive (individually a “Party” and together the “Parties”) agree as follows:

1.Section 5(a)(i) of the 2015 Agreement is stricken in its entirety and replaced with the following:

(i)the Company shall pay to the Executive in a lump sum in cash on the 60th day (except as specifically provided in Section 5(a)(i)(A)(2)) after the Date of Termination the aggregate of the following amounts:

A.the sum of (1) the Executive’s accrued but unpaid Annual Base Salary and any accrued but unused vacation pay through the Date of Termination, and (2) the Executive’s Annual Bonus for the fiscal year immediately preceding the fiscal year in which the Date of Termination occurs if such bonus has not been paid as of the Date of Termination (at the time such Annual Bonus would otherwise have been paid) (together, the “Accrued Obligations”); and  

B.the amount equal to the product of (x) 1.0 (or, if the Date of Termination occurs within the six month period prior to or the two-year period following a Change of Control (as defined in the Primerica, Inc. 2010 Omnibus Incentive Plan), 1.5), and (y) the sum of (I) the Executive’s Annual Base Salary as of the Date of Termination and (II) the Target Bonus as of the Date of Termination.

2.The amendments set forth herein are limited to the subject matter thereof. All other provisions of the 2015 Agreement shall remain unchanged.  

 

 [Signature page follows.]

 

 

 

IN WITNESS WHEREOF, the Executive has hereunto set the Executive’s hand and, pursuant to the authorization from its Board of Directors, the Company has caused these presents to be executed in its name and on its behalf, all as of the day and year first above written.

 

 /s/ Peter W. Schneider
PETER W. SCHNEIDER

PRIMERICA, INC.

By: /s/ P. George Benson
Title:  Lead Directorpri-ex1032_600.htm

 

EXHIBIT 10.32

AMENDMENT TO amended and RESTATED EMPLOYMENT AGREEMENT

AMENDMENT by and between Primerica, Inc. (the “Company”), and Alison S. Rand (the “Executive”) dated as of the 17th day of November, 2015.

WHEREAS, the Board of Directors of the Company (the “Board”) has previously determined that it is in the best interests of the Company and its stockholders to employ the Executive as the Company’s Executive Vice President and Chief Financial Officer;

WHEREAS, the Company and the Executive entered into an Amended and Restated Employment Agreement embodying the terms of such employment dated as of January 2, 2015 (the “2015 Agreement”); and

WHEREAS, the Company and the Executive desire to modify certain terms of the 2015 Agreement;

NOW, THEREFORE, in consideration of the premises and mutual covenants contained herein and for other good and valuable consideration, the receipt of which is mutually acknowledged, the Company and the Executive (individually a “Party” and together the “Parties”) agree as follows:

1.Section 5(a)(i) of the 2015 Agreement is stricken in its entirety and replaced with the following:

(i)the Company shall pay to the Executive in a lump sum in cash on the 60th day (except as specifically provided in Section 5(a)(i)(A)(2)) after the Date of Termination the aggregate of the following amounts:

A.the sum of (1) the Executive’s accrued but unpaid Annual Base Salary and any accrued but unused vacation pay through the Date of Termination, and (2) the Executive’s Annual Bonus for the fiscal year immediately preceding the fiscal year in which the Date of Termination occurs if such bonus has not been paid as of the Date of Termination (at the time such Annual Bonus would otherwise have been paid) (together, the “Accrued Obligations”); and  

B.the amount equal to the product of (x) 1.0 (or, if the Date of Termination occurs within the six month period prior to or the two-year period following a Change of Control (as defined in the Primerica, Inc. 2010 Omnibus Incentive Plan), 1.5), and (y) the sum of (I) the Executive’s Annual Base Salary as of the Date of Termination and (II) the Target Bonus as of the Date of Termination.

2.The amendments set forth herein are limited to the subject matter thereof. All other provisions of the 2015 Agreement shall remain unchanged.  

 

 [Signature page follows.]

 

 

 

IN WITNESS WHEREOF, the Executive has hereunto set the Executive’s hand and, pursuant to the authorization from its Board of Directors, the Company has caused these presents to be executed in its name and on its behalf, all as of the day and year first above written.

 

 /s/ Alison S. Rand
ALISON S. RAND 

PRIMERICA, INC.

By: /s/ P. George Benson
Title:  Lead Directorpri-ex1034_601.htm

 

EXHIBIT 10.34

AMENDMENT TO amended and RESTATED EMPLOYMENT AGREEMENT

AMENDMENT by and between Primerica, Inc. (the “Company”), and Gregory C. Pitts (the “Executive”) dated as of the 17th day of November, 2015.

WHEREAS, the Board of Directors of the Company (the “Board”) has previously determined that it is in the best interests of the Company and its stockholders to employ the Executive as the Company’s Executive Vice President and Chief Operating Officer;

WHEREAS, the Company and the Executive entered into an Amended and Restated Employment Agreement embodying the terms of such employment dated as of January 2, 2015 (the “2015 Agreement”); and

WHEREAS, the Company and the Executive desire to modify certain terms of the 2015 Agreement;

NOW, THEREFORE, in consideration of the premises and mutual covenants contained herein and for other good and valuable consideration, the receipt of which is mutually acknowledged, the Company and the Executive (individually a “Party” and together the “Parties”) agree as follows:

1.Section 5(a)(i) of the 2015 Agreement is stricken in its entirety and replaced with the following:

(i)the Company shall pay to the Executive in a lump sum in cash on the 60th day (except as specifically provided in Section 5(a)(i)(A)(2)) after the Date of Termination the aggregate of the following amounts:

A.the sum of (1) the Executive’s accrued but unpaid Annual Base Salary and any accrued but unused vacation pay through the Date of Termination, and (2) the Executive’s Annual Bonus for the fiscal year immediately preceding the fiscal year in which the Date of Termination occurs if such bonus has not been paid as of the Date of Termination (at the time such Annual Bonus would otherwise have been paid) (together, the “Accrued Obligations”); and  

B.the amount equal to the product of (x) 1.0 (or, if the Date of Termination occurs within the six month period prior to or the two-year period following a Change of Control (as defined in the Primerica, Inc. 2010 Omnibus Incentive Plan), 1.5), and (y) the sum of (I) the Executive’s Annual Base Salary as of the Date of Termination and (II) the Target Bonus as of the Date of Termination.

2.The amendments set forth herein are limited to the subject matter thereof. All other provisions of the 2015 Agreement shall remain unchanged.  

 

 [Signature page follows.]

 

 

 

IN WITNESS WHEREOF, the Executive has hereunto set the Executive’s hand and, pursuant to the authorization from its Board of Directors, the Company has caused these presents to be executed in its name and on its behalf, all as of the day and year first above written.

 

 /s/ Gregory C. Pitts
GREGORY C. PITTS 

PRIMERICA, INC.

By: /s/ P. George Benson
Title: Lead DirectorEX-10.11

 Exhibit 10.11 
  

 
 December 11, 2015 

Dear Jennifer, 
 It is our pleasure to extend an offer to you as
EVP Chief Risk Officer effective, January 1, 2016. The position will report to Mariner Kemper, Chairman, President, & CEO. 
 This letter is
to confirm the following details of our offer: 
  

	 	•	 	Effective January 4, 2016, a salary at a gross annual rate of $200,000, contingent upon approval by the Board Compensation Committee. Such salary shall be payable over 52 weeks as earned and in accordance with the
Company’s standard payroll procedures. 

  

	 	•	 	Effective July 4, 2016, a salary at a gross annual rate of $227,000, contingent upon approval by the Board Compensation Committee. Such salary shall be payable over 52 weeks as earned and in accordance with the
Company’s standard payroll procedures. 

  

	 	•	 	Eligibility to participate in the 2016 Short Term Incentive Program (STIP) contingent upon approval by the Board Compensation Committee, subject to all terms of the plan at a target of 35% of base pay.

  

	 	•	 	Eligibility to participate in the 2016 Long Term Incentive Program (LTIP) contingent upon approval by the Board Compensation Committee, subject to all terms of the plan at 50% of base pay.

 Please contact me if you have any questions. 

Congratulations on your new position! We wish you continued success in your UMB career. 

Sincerely, 
 Mariner Kemper 

Chairman & CEO 
 I have read and accept the terms and
conditions of this job offer. 
  

	
	                                      
                              
  DateExhibit

Exhibit 10.57

FOURTH AMENDMENT TO CONSULTING AGREEMENT

This fourth Amendment to the Consulting Agreement (this “Amendment”), is entered into as of November 27, 2015, by and among Pacira Pharmaceuticals, Inc., a California corporation (the “Company”) and Gary Pace (“Consultant”).

This Amendment amends the Third Amendment and Restated Consulting Agreement dated August 17, 20 I 2 by and among the Company, and Consultant (the “Original Agreement”). If there is any conflict between the provisions of this Amendment and those in the Original Agreement, the provisions of this Amendment govern. Except as expressly stated in this Amendment, capitalized terms used and not defined herein have the same meanings defined in the Original Agreement. Except as expressly amended herein, all other terms and provisions of the Original Agreement remain in full force and effect.

AGREEMENT

NOW, THEREFORE, in consideration of the representations, warranties and agreements contained in this Agreement and for other good and valuable consideration, the receipt of which the parties hereby acknowledge, the parties agree as follows

• Exhibit A to the Original Agreement is hereby amended in its entirety and replaced with the Exhibit A attached hereto.

IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by their duly authorized representatives, effective as of the date first written above.

	
			
	PACIRA PHARMACEUTICALS, INC.
	 
	GARY PACE

	 
	 
	 

	/s/ Daina Borteck
	 
	/s/ Gary W. Pace

	 
	 
	 

	Daina Borteck
	 
	Gary W. Pace

	Assistant General Counsel
	 
	Consultant

	December 22, 2015
	 
	November 27, 2015

EXHIBIT A

Scope of Services of Consultant:

The scope of consulting work contemplated by this Agreement shall be as follows: Consultant will act as a Technical advisor to the professional responsible for the management of the Science Center activities relating to the Company’s product development and manufacturing functions. Consultant will work as needed on an hourly  basis  with  a maximum of $5,000 per month.

Consulting Fees:

Consultant shall be compensated at the rate of $400 per hour, to be billed monthly via invoice. Invoices must be sent electronically to __________________ with copy to Pacira contact and shall be paid within thirty (30) days of receipt at Pacira of a correct and undisputed invoice.

Total charges of all billing not to exceed $5,000.00 per month.

Payment shall be made by direct deposit (preferred method - complete Exhibit B), wire transfer or by check payable to the following address:

Name & Address:

Gary W. Pace

Electronic Payment:

ON FILE

Company name:
Bank name:
Account number:
Routing ABA #
If paid by ACH remittance can be emailed to _______________.

EXHIBIT B

Complete and return Form W-9—Request for Taxpayer Identification Number and Certification along with the Consulting Agreement.

Reimbursement of Expenses:
		
	•
	Pacira Pharmaceuticals will reimburse consultant for all pre-approved travel and related expenses.

		
	•
	The consultant is responsible for making all travel arrangements through his/her travel agent, unless otherwise  instructed.

		
	•
	Expense reports should be submitted to Pacira with corresponding receipts within five (5) days of the completed  travel.

Pacira Pharmaceuticals Contact:

Name: James Scibetta
Title: President & CFO
Pacira Pharmaceuticals, Inc.
5 Sylvan Way, Suite 300
Parsippany, NJ 07054
Tel: (973) 254-3560
Fax: (973) 254-0060

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00254-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00254-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00254-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00254-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00254-of-00352.parquet"}]]